Fighting blindness with more funding: Durham startup Opus Genetics raises $4.5M

Opus Genetics, a Durham-based company developing drugs to treat retinal diseases has raised an additional $4.5 million from investors. Here's how the CEO plans to invest the money.

Related Keywords

United States ,North Carolina ,Charlotte ,Ben Yerxa ,Rd Fund ,Manning Family Foundation ,Exchange Commission ,Drug Administration ,Foundation Fighting Blindness ,Carolina Biotechnology Center ,Business North Carolina ,Bios Partners ,North Carolina Biotechnology ,